IL315871A - Aqueous composition - Google Patents

Aqueous composition

Info

Publication number
IL315871A
IL315871A IL315871A IL31587124A IL315871A IL 315871 A IL315871 A IL 315871A IL 315871 A IL315871 A IL 315871A IL 31587124 A IL31587124 A IL 31587124A IL 315871 A IL315871 A IL 315871A
Authority
IL
Israel
Prior art keywords
salts
buffer agents
esters
examples
acid buffer
Prior art date
Application number
IL315871A
Other languages
English (en)
Hebrew (he)
Inventor
ORITANI Rika
KITANI Chise
NISHIMOTO Akinori
Original Assignee
Tsubota Lab Inc
ORITANI Rika
KITANI Chise
NISHIMOTO Akinori
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Lab Inc, ORITANI Rika, KITANI Chise, NISHIMOTO Akinori filed Critical Tsubota Lab Inc
Publication of IL315871A publication Critical patent/IL315871A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1468—Containers characterised by specific material properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL315871A 2022-03-25 2023-03-24 Aqueous composition IL315871A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022050275 2022-03-25
PCT/JP2023/011739 WO2023182480A1 (ja) 2022-03-25 2023-03-24 水性組成物

Publications (1)

Publication Number Publication Date
IL315871A true IL315871A (en) 2024-11-01

Family

ID=88101709

Family Applications (1)

Application Number Title Priority Date Filing Date
IL315871A IL315871A (en) 2022-03-25 2023-03-24 Aqueous composition

Country Status (14)

Country Link
US (1) US20250213510A1 (https=)
EP (1) EP4483867A1 (https=)
JP (1) JPWO2023182480A1 (https=)
KR (1) KR20240159636A (https=)
CN (1) CN118973561A (https=)
AU (1) AU2023240729A1 (https=)
CA (1) CA3254664A1 (https=)
CL (1) CL2024002831A1 (https=)
IL (1) IL315871A (https=)
MA (1) MA67594B1 (https=)
MX (1) MX2024011634A (https=)
PE (1) PE20250746A1 (https=)
TW (1) TW202400133A (https=)
WO (1) WO2023182480A1 (https=)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4806956B2 (ja) * 2004-04-20 2011-11-02 大正製薬株式会社 点眼用液剤
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
JP2009078977A (ja) * 2007-09-25 2009-04-16 Japan Health Science Foundation 心筋の小胞体ストレス抑制剤
EP2127638A1 (en) * 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
US8962686B2 (en) * 2010-04-28 2015-02-24 The Chinese University Of Hong Kong Method and medication for prevention and treatment of ocular hypertension and glaucoma
WO2018164113A1 (ja) * 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
WO2018181294A1 (ja) * 2017-03-27 2018-10-04 興和株式会社 医薬製剤
JP7474706B2 (ja) 2018-12-18 2024-04-25 参天製薬株式会社 ４－フェニル酪酸を含有する老視の治療または予防剤

Also Published As

Publication number Publication date
TW202400133A (zh) 2024-01-01
US20250213510A1 (en) 2025-07-03
CN118973561A (zh) 2024-11-15
CA3254664A1 (en) 2025-07-03
PE20250746A1 (es) 2025-03-13
MA67594A1 (fr) 2025-07-31
CL2024002831A1 (es) 2025-01-24
JPWO2023182480A1 (https=) 2023-09-28
MA67594B1 (fr) 2026-01-30
WO2023182480A1 (ja) 2023-09-28
EP4483867A1 (en) 2025-01-01
AU2023240729A1 (en) 2024-10-03
KR20240159636A (ko) 2024-11-05
MX2024011634A (es) 2024-09-30

Similar Documents

Publication Publication Date Title
AR043863A1 (es) Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines
JP6009141B2 (ja) 水性組成物
EP0937395B1 (en) Disinfecting and sterilizing concentrate containing an aromatic dialdehyde and a neutral ph buffering system
JPS6210209B2 (https=)
IL315871A (en) Aqueous composition
PL342822A1 (en) Pharmacological compositions containing sodium {[3-(amino-1,2-dipxyethyl)-2-ethyl-1-phenylmethyl)-1h-idol-4-yl]-4-oxy} acetate as a phosphpolipase inhibitor
RU2006101676A (ru) Композиции для полоскания полости рта, содержащие соли алкиловых эфиров n-ациларгинина
ZA200005238B (en) Pyrrolidines as inhibitors of neuraminidases.
US20190240247A1 (en) Pharmaceutical formulations of regadenoson
JPS621792A (ja) 漂白剤組成物
JP2018044013A (ja) 水性組成物
JP7559336B2 (ja) 液体製剤中の酵素の安定化方法
AU2010235948B2 (en) Stabilized and preserved ketotifen ophthalmic compositions
CA2581156A1 (en) Stabilized leukotriene b4 (ltb4) agent pharmaceutical formulation
GB811717A (en) Improvements in or relating to therapeutic compositions
MXPA05002719A (es) Formula de una solucion liquida para aplicacion en el oido externo (conducto auditivo externo) como preventivo de la otitis externa.
WO2024010040A1 (ja) 眼科組成物
JP2003063963A (ja) オザグレルナトリウム含有注射液
JPH03227907A (ja) 皮膚化粧料
JP2002173422A (ja) 脳室洗浄製剤
JP2017002042A (ja) 点眼剤、及び点眼剤防腐効力維持方法
JP2019210288A (ja) 水性液剤
CN117204428A (zh) 低腐蚀性高稳定性耐硬水的过氧乙酸消毒液及其制备方法
JPS62163689A (ja) アミノアシラ−ゼ溶液の安定化法
JPH1088095A (ja) 固形状接着剤